186 related articles for article (PubMed ID: 32769887)
1. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.
Zhou W; Chang A; Zhao H; Ye H; Li D; Zhuo X
Cancer Biomark; 2020; 27(4):533-539. PubMed ID: 32083569
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
4. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
7. Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis.
Zhang L; Lu D; Liu M; Zhang M; Peng Q
Mol Med Rep; 2019 Sep; 20(3):2316-2324. PubMed ID: 31322209
[TBL] [Abstract][Full Text] [Related]
8. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
11. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma.
Guo Y; Zhang Y; Zhang SJ; Ma YN; He Y
BMC Med Genomics; 2019 May; 12(1):73. PubMed ID: 31138194
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
15. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
Pan X; Liu JH
Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
[TBL] [Abstract][Full Text] [Related]
16. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
17. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
20. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
Wang B; Wang W; Wang H; Liu W
Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
